Başoğlu, T. Et Al. 2022. Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.. Revista espanola de medicina nuclear e imagen molecular , vol.41, no.3 , 171-178.

Başoğlu, T., Özgüven, S., Özkan, H. Ş., Çınar, M., Köstek, O., Demircan, N. C., ... Arıkan, R.(2022). Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.. Revista espanola de medicina nuclear e imagen molecular , vol.41, no.3, 171-178.

Başoğlu, Tuğba Et Al. "Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.," Revista espanola de medicina nuclear e imagen molecular , vol.41, no.3, 171-178, 2022

Başoğlu, Tuğba Et Al. "Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.." Revista espanola de medicina nuclear e imagen molecular , vol.41, no.3, pp.171-178, 2022

Başoğlu, T. Et Al. (2022) . "Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.." Revista espanola de medicina nuclear e imagen molecular , vol.41, no.3, pp.171-178.

@article{article, author={Tuğba Başoğlu Et Al. }, title={Predictive value of (18)F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy.}, journal={Revista espanola de medicina nuclear e imagen molecular}, year=2022, pages={171-178} }